George Elston's Net Worth
$1.74 Million
Who is George Elston?
George Elston has an estimated net worth of $1.74 Million. This is based on reported shares across multiple companies, which include Celldex Therapeutics, Inc., EyePoint Pharmaceuticals, Inc., and JUNIPER PHARMACEUTICALS INC.
SEC CIK
George Elston's CIK is 0001429932
Past Insider Trading and Trends
2023 was George Elston's most active year for acquiring shares with 7 total transactions. George Elston's most active month to acquire stocks was the month of May. 2022 was George Elston's most active year for disposing of shares, totalling 2 transactions. George Elston's most active month to dispose stocks was the month of January. 2019 saw George Elston paying a total of $14,290.00 for 755,000 shares, this is the most they've acquired in one year. In 2022 George Elston cashed out on 6,687 shares for a total of $17,433.73, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $38.195
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +54.05% | 10K |
—
|
—
| 28.5K |
Jun 8
| |||
Form 4
| +54.17% | 6.5K |
—
|
—
| 18.5K |
Jun 10
| |||
Form 4
| +20.00% | 2K |
—
|
—
| 12K |
Jun 4
| |||
Form 4
| +25.00% | 2K |
—
|
—
| 10K |
Jun 19
| |||
Form 4
| +33.33% | 2K |
—
|
—
| 8K |
Jun 20
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Sep 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $29.32
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.88% | 3.87K |
$11.16 | -$40,477.32 | 47.48K |
May 25
| |||
Form 4
| +21.13% | 7.61K |
$28.80 | -$91,929.60 | 43.61K |
Feb 9
| |||
Form 4
| +41.61% | 10.37K |
$20.40 | -$100,184.40 | 35.31K |
Jan 5 - Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +87.69% | 10.8K |
—
|
—
| 23.12K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +51.05% | 3.25K |
$10.13 | -$17,433.73 | 9.6K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +33.33% | 10K |
$0.48 | $4,800.00 | 40K |
Sep 4
| |||
Form 4
| +50.00% | 10K |
$0.61 | $6,112.00 | 30K |
Aug 24
| |||
Form 4
| +100.00% | 10K |
$0.96 | $9,600.00 | 20K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
∞
| 10K |
$1.43 | $14,290.00 | 10K |
Nov 14 - Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
JUNIPER PHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1K |
$5.50 | $5,500.00 | 1K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
| No matching records found | |||||||||